联合血清AFP与CEUS LI-RADS提高中国高危患者诊断效能
该回顾性研究纳入152例高危患者的152个经组织学证实结节,评估联合LR-M与不同AFP阈值将结节重分类为LR-5对CEUS LI-RADS诊断效能的影响。结果显示,修订版LR-5(AFP>200或400 ng/ml)诊断HCC的敏感度从52.5%提高至69.2%或65.0%,特异度未受损;LR-M重分类后诊断非HCC恶性肿瘤的特异度提高,敏感度无显著降低。
要点
- 联合AFP>200 ng/ml将LR-M重分类为LR-5可提高HCC诊断敏感度至69.2%。
- 重分类后LR-M诊断非HCC恶性肿瘤特异度提高,敏感度无显著降低。
- 对>20 mm结节,修订版LR-5敏感度提高,特异度和PPV不变。
核心结论
- 将伴有AFP升高的LR-M结节重分类为LR-5可进一步提高CEUS LI-RADS的诊断效能。
研究设计与样本
- 回顾性研究,纳入152例高危患者的152个经组织学证实的结节,评估联合LR-M与不同AFP阈值重分类为LR-5的CEUS LI-RADS版本。
诊断标准与关键数值
- 修订版LR-5(AFP>200 ng/ml)诊断HCC的敏感度为69.2%,特异度为71.9%;修订版LR-5(AFP>400 ng/ml)敏感度为65.0%,特异度为78.1%;原始版LR-5敏感度为52.5%,特异度为87.5%。
- 重分类后LR-M诊断非HCC恶性肿瘤的特异度分别为84.4%(AFP>200 ng/ml)和80.7%(AFP>400 ng/ml),敏感度分别为70.6%和82.4%;原始LR-M敏感度100.0%,特异度69.6%。
- 对>20 mm结节,修订版LR-5的敏感度分别为69.1%(AFP>200 ng/ml)和64.9%(AFP>400 ng/ml),特异度和PPV不变。
临床应用与阅片要点
- 对于CEUS LI-RADS LR-M结节,若AFP>200 ng/ml可考虑重分类为LR-5以提高HCC诊断敏感度。
- 重分类可能降低非HCC恶性肿瘤的检出敏感度,需结合临床和其他影像综合判断。
局限性
- 回顾性单中心研究,样本量有限,结论需外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To evaluate and compare the diagnostic performance of revised contrast-enhanced ultrasound (CEUS) Liver Imaging Reporting and Data System version by combining LR-M category and serum alpha-fetoprotein (AFP) under different cut-off values.
MATERIAL AND METHODS: This retrospective study enrolled 152 high-risk patients with 152 histology-proven nodules. For revised LI-RADS, nodules in LR-M with different elevated AFP thresholds have been reclassified as the LR-5 category. The diagnostic performances of original and revised CEUS LI-RADS were evaluated and compared.
RESULTS: To compare with the original version, the sensitivity of revised LR-5 (adjusted with AFP value > 200 ng/ml or 400 ng/ml) for the diagnosis of hepatocellular carcinoma (HCC) improved from 52.5 to 69.2% or 65.0%, respectively (both p < 0.001) without compromising specificity (87.5% vs. 71.9% or 78.1%, respectively, both p > 0.05). For the diagnosis of non-HCC malignancy, the specificity of the LR-M after reclassification was improved (69.6% vs. 84.4% or 80.7%, respectively, both p < 0.001) with a non-significant sensitivity reduction (100.0 vs. 70.6% or 82.4%, respectively, both p > 0.05). After modification, the sensitivity of LR-5 also increased to 69.1% or 64.9% (both p < 0.001), while the specificity and PPV did not change (both p > 0.05) for larger nodules (> 20 mm).
CONCLUSION: The diagnostic performance of CEUS LI-RADS can be further improved by reclassifying LR-M nodules with elevated AFP thresholds to LR-5.
引用
- Gong, Wu, Wei, et al. Combining serum AFP and CEUS LI-RADS for better diagnostic performance in Chinese high-risk patients. Radiol Med. 2023. PMID: 36943653. doi:10.1007/s11547-023-01614-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。